Impact of Adjuvant Hormone Therapy on Bone and Cardiovascular Risk
Condition:   Breast Cancer Intervention:   Other: Questionnaire Sponsor:   University Hospital, Toulouse Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 17, 2021 Category: Research Source Type: clinical trials

Study of LY3484356 Versus Hormone Therapy, in Participants With Estrogen Receptor Positive (ER+), Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast Cancer
Conditions:   Breast Neoplasms;   Neoplasm Metastasis Interventions:   Drug: LY3484356;   Drug: Exemestane;   Drug: Fulvestrant Sponsor:   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2021 Category: Research Source Type: clinical trials

Assessment of Adherence, Quality of Life, Clinical Response and Safety of Daily and Long-Acting Growth Hormone Therapy
Conditions:   Growth Hormone Deficiency;   Growth Hormone Treatment Intervention:   Drug: Long-Acting Growth Hormone (LAGH) Sponsor:   University of Minnesota Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 24, 2021 Category: Research Source Type: clinical trials

Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
Conditions:   Transgender;   Cisgender Interventions:   Drug: Atorvastatin;   Other: placebo Sponsor:   Yale University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 10, 2021 Category: Research Source Type: clinical trials

Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
Conditions:   Hypertension;   Hyperlipidemias Interventions:   Drug: Atorvastatin;   Other: placebo Sponsor:   Yale University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 10, 2021 Category: Research Source Type: clinical trials